Tag: HFpEF (heart failure with preserved ejection fraction

Click here to to read this study in NEJM.  ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...

1. Semaglutide showed significant improvements in KCCQ-CSS score and reduction in body weight compared to placebo. 2. There were fewer ...

1. Sodium-glucose cotransporter-2 inhibitors (SGLT2-I) in combination with standard of care were found to increase quality-adjusted life-years at a cost ...

1. Quality of life at one year was improved in patients with heart failure with preserved ejection fraction (HFpEF) who ...

1. In this pooled analysis of 11,007 patients with heart failure in the DAPA-HF and DELIVER trials, treatment with dapagliflozin ...

1. Dapagliflozin was shown to reduce the risk of disease progression and cardiovascular death in patients with a mildly reduced ...

1. Dapagliflozin was shown to reduce the risk of disease progression and cardiovascular death in patients with a mildly reduced ...

1. The simple score comprised of 3 clinical (age, male sex, hypertension diagnosis) and 3 echocardiographic (ejection faction, posterior wall ...

1. SGLT-2 inhibitors reduced time to first hospitalization and cardiovascular death among patients with preserved, mildly reduced, and reduced ejection ...

1. In this randomized, controlled trial, for patients with heart failure and left ventricular ejection fraction higher than 40%, sacubitril/valsartan ...